Evidence map›Paper›PMID 24514099›Full record

ArticleAntimicrobial agents and chemotherapy2014

Outbreak caused by NDM-1- and RmtB-producing Escherichia coli in Bulgaria.

Laurent Poirel, Encho Savov, Arzu Nazli, Angelina Trifonova, Iva Todorova, Ivanka Gergova, Patrice Nordmann

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Emergence ofAntibiotics (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Dissemination of High-Risk ClonesMicroorganisms · 2022
    Article
  6. NDM-5-ProducingAnimals : an open access journal from MDPI · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Present and Future of Carbapenem-resistantAntibiotics (Basel, Switzerland) · 2019
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Aminoglycosides: An Overview.Cold Spring Harbor perspectives in medicine · 2016
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laurent PoirelMedical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland.
Encho Savov
Arzu Nazli
Angelina Trifonova
Iva Todorova
Ivanka Gergova
Patrice Nordmann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Twelve consecutive carbapenem-resistant Escherichia coli isolates were recovered from patients (infection or colonization) hospitalized between March and September 2012 in different units at a hospital in Bulgaria. They all produced the carbapenemase NDM-1 and the extended-spectrum-β-lactamase CTX-M-15, together with the 16S rRNA methylase RmtB, conferring high-level resistance to all aminoglycosides. All those isolates were clonally related and belonged to the same sequence type, ST101. In addition to being the first to identify NDM-producing isolates in Bulgaria, this is the very first study reporting an outbreak of NDM-1-producing E. coli in the world.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesBulgariaEscherichia coliAnti-Bacterial Agentsbeta-lactamase CTX-M-15beta-lactamase NDM-1beta-Lactamases

Identifiers

PMID24514099
PMCPMC4023783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.